Literature DB >> 20920743

Introduction: epigenetics and cancer.

Zdenko Herceg1, Toshikazu Ushijima.   

Abstract

The field of epigenetics has witnessed a recent explosion in our knowledge on the importance of epigenetic events in the control of both normal cellular processes and abnormal events associated with diseases, moving this field to the forefront of biomedical research. Advances in the field of cancer epigenetics and epigenomics have turned academic, medical, and public attention to the potential application of epigenetics in cancer control. A tremendous pace of discovery in this field requires that these recent conceptual breakthroughs and technological state-of-the-art in epigenetics and epigenomics are updated and summarized in one book with cancer focus. This book is primarily intended to academic and professional audience; however, an attempt has been made to make it understandable by and appealing to a wider audience among healthcare workers. The main aim of this book is to produce an authoritative and comprehensive reference source in print and online, covering all critical aspects of epigenetics and epigenomics and their implications in cancer research. This book discusses the state of science and determines the future research needs, covering most recent advances, both conceptual and technological, and their implication for better understanding of molecular mechanisms of cancer development and progression, early detection, risk assessment, and prevention of cancer. In this chapter, we describe the main aim and scope of this book and provide a brief emphasis of each of 22 chapters regrouped into eight major parts.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20920743     DOI: 10.1016/B978-0-12-380866-0.60001-0

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  10 in total

Review 1.  Aberrant DNA methylation in human cancers.

Authors:  Wen Li; Bi-Feng Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

Review 2.  Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.

Authors:  Yasushi Toh; Akinori Egashira; Manabu Yamamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-03-26

3.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  p53 Ser15 phosphorylation and histone modifications contribute to IR-induced miR-34a transcription in mammary epithelial cells.

Authors:  Bo Wang; Dongping Li; Olga Kovalchuk
Journal:  Cell Cycle       Date:  2013-06-06       Impact factor: 4.534

5.  Global DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study.

Authors:  Lisa A Deroo; Sophia C E Bolick; Zongli Xu; David M Umbach; David Shore; Clarice R Weinberg; Dale P Sandler; Jack A Taylor
Journal:  Carcinogenesis       Date:  2013-10-15       Impact factor: 4.944

Review 6.  Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.

Authors:  Federico Andreoli; Arménio Jorge Moura Barbosa; Marco Daniele Parenti; Alberto Del Rio
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.310

7.  Epigenetic mechanisms of pulmonary hypertension.

Authors:  Gene H Kim; John J Ryan; Glenn Marsboom; Stephen L Archer
Journal:  Pulm Circ       Date:  2011 Jul-Sep       Impact factor: 3.017

8.  Identifying Methylation Pattern and Genes Associated with Breast Cancer Subtypes.

Authors:  Lei Chen; Tao Zeng; Xiaoyong Pan; Yu-Hang Zhang; Tao Huang; Yu-Dong Cai
Journal:  Int J Mol Sci       Date:  2019-08-31       Impact factor: 5.923

9.  The impact of CBP expression in estrogen receptor-positive breast cancer.

Authors:  Wafaa S Ramadan; Iman M Talaat; Mahmood Y Hachim; Annette Lischka; Timo Gemoll; Raafat El-Awady
Journal:  Clin Epigenetics       Date:  2021-04-07       Impact factor: 6.551

Review 10.  ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.

Authors:  David Vrana; Viktor Hlavac; Veronika Brynychova; Radka Vaclavikova; Cestmir Neoral; Jiri Vrba; Rene Aujesky; Marcel Matzenauer; Bohuslav Melichar; Pavel Soucek
Journal:  Int J Mol Sci       Date:  2018-03-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.